Care management systems widely used in Italy

Italy's care management tool market is dominated by Dedalus, Engineering Group, GPI, and Exprivia in hospitals, with Millewin, Medikey, and Lynx serving primary care. All operate within a regionally fragmented system increasingly shaped by Fascicolo Sanitario Elettronico (FSE) 2.0 interoperability requirements and investment funded through the Piano Nazionale di Ripresa e Resilienza (PNRR).

How Italy's health system structure shapes tool adoption

Italy's Servizio Sanitario Nazionale (SSN), the national health service, operates across 21 regions, each with significant administrative and financial autonomy over health IT procurement. Platform adoption is rarely national in scope. It's typically regional, and sometimes sub-regional, determined by the priorities and budgets of individual Aziende Sanitarie, the regional health authorities. A platform that dominates in Lombardia may have minimal presence in Calabria. Regional health IT initiatives such as SISS in Lombardia and SOLE in Emilia-Romagna have created distinct technology ecosystems, and vendors need to integrate with these ecosystems to compete for contracts.

The care setting also matters. Italy distinguishes between three main contexts: primary care, delivered largely by Medici di Medicina Generale (MMGs), general practitioners who operate semi-independently and use dedicated practice management software; secondary care in hospitals and specialist outpatient settings, where full hospital information systems are deployed; and integrated community care, increasingly delivered through the emerging Case della Comunità network, a PNRR-funded model designed to coordinate chronic disease management and preventive care outside hospital walls. Tool adoption differs significantly across these settings, and decision-makers should be clear about which care context they're procuring for.

What "care management system" means in the Italian context

The term doesn't map neatly onto a single product category. In practice, it spans several distinct tools. The Cartella Clinica Elettronica (CCE) is the Italian equivalent of a clinical record system, used to document encounters and manage patient records within a single facility. The Fascicolo Sanitario Elettronico (FSE) is the national patient health summary, accessible across providers and regions. Hospital Information Systems (HIS) manage admissions, scheduling, billing, and resource allocation. Dedicated primary care management software serves general practitioners. Telemedicine and remote monitoring platforms are increasingly funded through PNRR.

Procurement discussions often conflate the CCE and FSE, but the distinction is material. The CCE is a facility-level documentation tool; the FSE is a longitudinal record that spans the whole system. Decision-makers evaluating platforms should be precise about which function they're procuring for, since vendors sometimes blur the line between the two.

According to data from the Osservatorio Sanità Digitale 2025 at the Politecnico di Milano School of Management, 85 per cent of Italian healthcare facilities now have an active CCE, and digital health investment reached €2.47 billion in 2024, a 12 per cent increase on the previous year.

The most widely used care management platforms in Italy

Dedalus is widely regarded as the leading health IT provider in Italy and across Europe. Its portfolio spans CCE, radiology information systems, laboratory systems, and care coordination platforms, with installations across public hospitals, regional health authorities, and diagnostic networks throughout Italy. Its Dedalus DC4H (Digital Connect 4 Health) platform is built on an open, FHIR-based architecture, meaning it uses Fast Healthcare Interoperability Resources standards to exchange clinical data across care settings, which is directly relevant to FSE 2.0 requirements. Dedalus has historically absorbed several Italian and European health IT businesses, including Agfa HealthCare's clinical software division, giving it a substantial base of existing installations across Italian public health organisations. Switching costs in public health IT are high, and that installed base represents a durable competitive advantage that new entrants find difficult to displace.

Engineering Group is one of Italy's largest IT services companies and a major supplier of hospital information systems to public health organisations. Its AREAS suite covers admissions, discharge, and transfer management, emergency department management, and clinical workflow. A procurement document from AULSS 9 Scaligera in Veneto lists Engineering's AREAS-ADTWeb and AREAS-PSWeb systems as active in that trust alongside platforms from Dedalus, GPI, and Exprivia, a good illustration of the multi-vendor reality typical of Italian public health IT environments.

GPI S.p.A. has secured some of the largest CCE procurement contracts in Italy in recent years. Most notably, GPI won the public tender to deliver the regional CCE for healthcare entities in Lombardia, Italy's largest region by population and GDP, in a contract reported to be worth €32.7 million. Its IE-DEA and IE-Cartella systems are also listed as active in Veneto's AULSS 9 Scaligera procurement documentation, suggesting multi-region deployment.

Exprivia is an Italian technology group with a dedicated healthcare division. Its CCE suite manages the full patient journey from admission to discharge, and its ERIS RIS/PACS system handles radiology information and imaging workflows. Exprivia is in active use within Veneto's regional health infrastructure and appears among the key vendors in the Polimi observatory's partner ecosystem.

InterSystems TrakCare is an international unified healthcare platform with adoption across Italian secondary care settings. Its strengths lie in interoperability, structured clinical data management, and presenting a unified patient record across departments. Italian market analysis places InterSystems alongside Dedalus, Exprivia, and Engineering as one of the dominant systems in the Italian hospital software market, making it particularly relevant for organisations that prioritise cross-departmental clinical data integration under FSE 2.0.

International platforms including Philips TASY and Oracle Health (formerly Cerner) appear in specific Italian hospital networks and private care groups, focused on clinical documentation, care coordination, and hospital operations management. They tend to appear in larger private hospital groups or public institutions that have pursued international procurement frameworks, rather than in the typical regional health authority context where domestic vendors predominate. Oracle Health is listed as a named partner of the Osservatorio Sanità Digitale 2025, indicating an active commercial presence in the Italian market.

FSE 2.0: the interoperability requirement that reshapes every procurement

The Fascicolo Sanitario Elettronico 2.0 functions as the foundational interoperability layer that all care management tools in Italy must now connect with. It gives patients access to their longitudinal health record across providers and regions, and it requires all clinical systems to share structured clinical documentation in standardised FHIR-based formats. FSE 2.0 compliance has become a de facto procurement requirement. Vendors that can't demonstrate integration with the national framework face significant barriers to winning public contracts. Of all the regulatory and funding forces currently shaping the Italian market, this is the one that most directly determines which vendors can compete.

The gap between policy intent and operational reality remains wide, however. A 2026 update from the Polimi observatory found that only 48 per cent of specialist doctors had accessed the FSE, and identified the lack of integration between hospital systems and the FSE as a key barrier to care continuity, even as the FSE is treated as a solved problem in many procurement conversations.

Primary care: a distinct procurement environment

Italian general practitioners operate in a distinct procurement environment from hospitals. They typically select practice management software independently or through their regional health authority. The most widely used GP platforms, Millewin, Medikey, and Lynx, handle daily clinical documentation, chronic disease follow-up, sick note generation, patient letters, and integration with regional Centro Unico di Prenotazione (CUP) centralised booking systems. Connecting these platforms to the FSE 2.0 national framework is an ongoing area of development, as the national framework requires GP-level data to feed into each patient's longitudinal record.

Emerging tools: telemedicine, remote monitoring, and AI

PNRR funding through the Missione 6 Salute programme has accelerated investment in digital tools beyond the core CCE. Telemedicine and remote consultation platforms have expanded significantly since 2021, supported by national Ministry of Health guidelines and regional rollout programmes. Chronic disease pathways for diabetes, cardiovascular disease, and respiratory conditions increasingly incorporate structured remote monitoring. The EU-funded GATEKEEPER project, which included Italy as one of seven European implementation sites, piloted a joined-up digital health framework for ageing populations, testing wearable-based monitoring for chronic obstructive pulmonary disease (COPD) and heart failure, glycaemic management for diabetes, and machine learning-based predictions for hypertension.

Artificial intelligence integration in clinical workflows is an early but growing area. Survey data from the 2026 Polimi observatory update found that 61 per cent of surveyed specialists and general practitioners reported having used generative AI tools in some capacity, though this figure reflects self-reported usage and should be verified for sample size and methodology before being cited in procurement arguments. Clinical decision support and AI-assisted documentation are the most common entry points, but formal integration into certified care management platforms remains limited. A systematic review of machine learning applied to administrative health records found that while the field is accelerating, studies remain largely disconnected from one another, and data quality limitations constrain the usefulness of analytics tools in practice. Decision-makers should treat vendor claims about AI-driven capabilities with scepticism until those capabilities have been validated in the Italian regulatory and clinical context.

What drives adoption and what slows it

PNRR funding has created time-bound financial incentives tied to CCE rollout, FSE 2.0 integration, and telemedicine capacity. FSE 2.0 compliance requirements are reshaping procurement decisions by effectively requiring interoperability standards that favour vendors with proven national framework integration. Regional health IT strategies in more advanced regions, Lombardia, Emilia-Romagna, Veneto, and Toscana, are driving coordinated platform consolidation and creating reference models for other regions to follow.

Four barriers recur consistently against these drivers. Legacy system dependencies are significant: as documented by Arcadia, citing data from the Italian National Institute of Statistics (ISTAT) and the National Agency for Regional Health Services (AGENAS), technological, training, and regulatory gaps mean digitalisation is incomplete across many facilities. Regional fragmentation produces inconsistent implementation timelines and varying local technical capacity. The lack of integration between hospital systems and the FSE disrupts care continuity. And clinician resistance to the added paperwork load slows uptake where new platforms increase administrative work without reducing the cognitive demands on staff, regardless of organisational mandate.

What decision-makers should evaluate when assessing these platforms

For healthcare decision-makers in Italy, whether in a regional health authority, a hospital, or a private group, the most practically relevant criteria when assessing care management platforms are set out below. Not all carry equal weight in every context, and the order of priority will depend on the specific care setting.

FSE 2.0 compliance and FHIR-based interoperability is non-negotiable for public sector procurement. The platform must be able to exchange structured clinical data with the national FSE framework. Closely related is the question of regional reference sites: does the vendor have active, verifiable deployments in your region or in comparable ones? The multi-vendor environment documented in trusts like AULSS 9 Scaligera illustrates why understanding local integration history matters.

Integration with existing legacy systems is a separate but equally practical concern. Decision-makers should ask what middleware or application programming interface (API) capability the platform offers to connect with the hospital information systems, radiology, laboratory, and scheduling tools already in use. On data governance, General Data Protection Regulation (GDPR) alignment requires clarity on where patient data is processed and stored. Italian public-sector cloud rules set by the Agenzia per la Cybersicurezza Nazionale (ACN) may impose additional requirements, and ISO 27001 certification is a baseline security expectation.

Support for structured clinical notes and coding using standards such as SNOMED CT and ICD matters most when the goal is reducing the administrative load on clinicians rather than adding to it. Finally, Italian public health procurement typically involves long contract cycles, which makes vendor financial stability, local support capacity, and a transparent product roadmap material considerations. So is whether the platform is designed for the specific care context, primary, secondary, or integrated community care, in which it will be deployed.

Frequently asked questions

▶ Which care management platforms are most widely used in Italian hospitals?

Dedalus, Engineering Group, GPI, and Exprivia dominate public hospital tenders. In practice, a single trust often runs several of these simultaneously: AULSS 9 Scaligera in Veneto operates active systems from all four vendors alongside InterSystems TrakCare. Assuming one vendor owns a region is a common procurement mistake.

▶ What is the difference between the Cartella Clinica Elettronica and the Fascicolo Sanitario Elettronico?

The CCE belongs to a single facility and closes when the patient leaves. The FSE follows the patient across every provider and region for life. Vendors sometimes market CCE products as FSE solutions, so procurement teams should ask specifically which function a platform is licensed and certified to perform.

▶ Why is Italy's care management tool market so fragmented?

Each of Italy's 21 regions procures health IT independently, and regional platforms such as SISS in Lombardia and SOLE in Emilia-Romagna have built distinct ecosystems over many years. A vendor without existing integration into a region's ecosystem faces a structural disadvantage that price alone cannot overcome.

▶ What software do Italian general practitioners use for clinical documentation?

Millewin, Medikey, and Lynx are the dominant options. GPs often select these independently rather than through a hospital procurement process, which means FSE 2.0 integration at the primary care level is patchy and remains an active area of development rather than a solved problem.

▶ What is FSE 2.0 and why does it matter for procurement decisions?

FSE 2.0 is Italy's national interoperability framework requiring clinical systems to exchange structured data using FHIR standards. It functions as a pass-or-fail filter in public tenders. The Polimi observatory's 2026 update found only 48 per cent of specialist doctors had accessed the FSE, which signals that compliance on paper and working integration in practice are still two different things.

▶ How has PNRR funding shaped digital health investment in Italy?

PNRR funding comes with fixed delivery deadlines, which has pushed organisations to commit to platforms faster than a normal procurement cycle would allow. That time pressure favours vendors with proven regional deployments and ready-made FSE 2.0 integrations over newer entrants, regardless of feature comparisons.

▶ What are the main barriers to care management platform adoption in Italy?

Legacy dependencies, regional fragmentation, incomplete FSE integration, and clinician resistance to added documentation load all recur. Of these, clinician resistance is the one most often underestimated at the procurement stage and most likely to determine whether a platform is actually used after go-live.

▶ What role is AI playing in Italian clinical workflows?

The Polimi observatory's 2026 update found 61 per cent of surveyed clinicians had used generative AI tools in some capacity, but this is self-reported usage, not certified platform integration. Before accepting vendor AI claims, ask whether the capability has been validated against Italian regulatory requirements and tested on Italian clinical data.

▶ What criteria should decision-makers use when evaluating care management platforms in Italy?

Verified FSE 2.0 integration, active reference sites in your region, API capability for legacy connections, GDPR and ACN cloud compliance, structured coding support, and vendor financial stability all matter. Weight them in the order that reflects your care setting: a Case della Comunità hub has different priorities than a large acute hospital.

▶ What are the Case della Comunità and how do they affect tool selection?

These PNRR-funded community health hubs sit between GP practices and hospitals in terms of clinical complexity and workflow. Most current platforms were built for one of those two settings. Procurement teams should ask vendors for Case della Comunità reference sites specifically, rather than accepting hospital or GP deployments as equivalent evidence.